RP UFLC method for estimation of valsartan chemometricaly
1 Department of pharmaceutical chemistry, Shri venkateshwara college of pharmacy, Pudhucherry, India.
2 Shri Jagdishprasad Jhabarmal Tibrewala University, Jhunjhunu, Rajasthan, India.
Research Article
World Journal of Advanced Research and Reviews, 2023, 18(02), 415–426
Article DOI: 10.30574/wjarr.2023.18.2.0847
Publication history:
Received on 31 March 2023; revised on 07 May 2023; accepted on 09 May 2023
Abstract:
A simple, sensitive, rapid, precise and economical reverse phase HPLC method has been developed for the estimation of valsartan from pharmaceutical dosage forms. The method was carried out using Chromatographic conditions were established by employing a C18 analytical phenomenal (Kinetex) column (5micron -C18, 250x4.6mm) with a mobile phase of phosphate buffer (PH 3.5) and acetonitrile in a 60:40 ratio. The sample was injected at a volume of 20 microliters, and the mobile phase was degassed using a Sonica ultrasonic sonicator before being pumped into the HPLC system. The flow rate was set at 1 ml per minute, and the wave length 273 nm was chosen for detection. The column temperature was kept at 25oC respectively. The developed method was validated in terms of accuracy, precision, linearity, limit of detection, limit of quantitation and solution stability. The proposed method can be used for the estimation of these drugs in dosage forms.
Keywords:
Valsartan; UFLC; Chemometricaly; Method development; Method validation
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0